Airfinity Ltd
Harry Cheeld has a work experience spanning from 2020 to the present. Harry started their career as a Genetic Technologist at Oncologica UK in November 2020, where they worked until March 2021. Harry then moved on to Airfinity Ltd, first as a Life Science Researcher from March to December 2021, then as an Analyst from December 2021 to December 2022. Currently, Harry holds the position of Senior Analyst at Airfinity Ltd, starting in January 2023.
Harry Cheeld attended The University of Sheffield where they obtained a Master's degree in Research (MRes). The specific field of study during this time is not provided. No information regarding the start and end date of this education is given.
Airfinity Ltd
Airfinity is a pioneer in predictive health analytics that decision makers can trust, understand and act on to preempt future health risks.Specialising in infectious diseases, Airfinity has a comprehensive suite of world-leading market intelligence solutions, turning disconnected data points into real time predictive indicators. The platform alsocovers advanced therapies (e.g. RNA, Gene and Cell Therapy) and cardio-metabolic.Disease-centric solutions combine proprietary surveillance tools and forecast models with expert analysis to produce actionable insights on pipeline developments, standard of care, regulatory trends and demand and supply.Airfinity is a global company with headquarters in London and Boston, relied upon across the full ecosystem in life sciences, including pharma companies, government agencies, corporates, investors, NGOs, and international organisations.